However, patients randomized to tic

However, patients randomized to ticagrelor had increased
incidence of dyspnea, a known adverse effect commonly
characterized as mild to moderate and often transient without
being associated with either differences in efficacy or safety
outcomes14 or an adverse effect on pulmonary function.15

結果 (中文) 1:

然而，增加患者随机分配到替卡格雷呼吸困难，通常已知的不良反应发生率特点为轻中度和不经常瞬态正在与任一疗效的差异或安全关联outcomes14 或肺 function.15 的不利影响

結果 (中文) 3:

然而，患者随机接受替卡格雷已经呼吸困难发生率增加
，已知的副作用通常表现为轻度至中度
往往不被用
瞬态差异在疗效和安全性
outcomes14或肺作用不良的影响有关